+1 212 479 6876 lcolahan@cooley.com
Lily Colahan's corporate practice includes advising public and private companies in a broad array of business activities and transactions, with a focus on the technology and life sciences sectors.
Download full bio
Oncorus – $98 Million IPO
COMPASS Pathways – $147 Million IPO
Vital Farms – $235.4 Million IPO
Karuna Therapeutics $103 million IPO
Akero Therapeutics - $106 Million IPO
View all
Capital Markets
Public Companies
Emerging Companies
Venture Capital
Fordham University School of LawJD, magna cum laude, 2014
Tufts UniversityBA, 2011
Massachusetts
New York
Vital Farms – $235.4 Million IPO August 11, 2020
Aquestive – $74 Million IPO September 12, 2018
+1 212 479 6876 office lcolahan@cooley.com
55 Hudson YardsNew York, NY 10001-2157